Free Newsletter
Courses target Chinese drug makers
Industry group ISPE is partnering with the China Centre for Pharmaceutical International Exchange (CCPIE) to bring training courses tailored to the needs of the Chinese pharmaceutical industry. Industry leader Gordon Farquharson will be presenting courses on sterile drug manufacturing facilities and pharmaceutical water systems.
The Sterile Drug Manufacturing Facilities: Applying ISPE Baseline Guide, FDA, EU/PICS and WHO Principles to Design and Operation course will review ISPE's sterile manufacturing facilities baseline guide, the FDA's 2004 Guidance for Industry: Sterile Drug Products Produced by Aseptic Processing--Current Good Manufacturing Practice, and the March 2009 implementation of Annex 1 of the EU GMP, according to an announcement. The course is intended to help participants understand the key requirements and GMPs for sterile product manufacturing facilities.
In the second course, Pharmaceutical Water Systems: Regulation, Purification, Distribution and Validation, participants will review the principles of design and operation of water systems used in pharmaceutical manufacturing, including the regulatory requirements, concepts, and principles for systems used to generate, store and distribute both compendial and non-compendial waters.
- read the course descriptions
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: